NCT02005029View on ClinicalTrials.gov

Erythromycin in Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Parkinson's DiseaseLevodopa
Interventions
DRUG

Erythromycin

DRUG

placebo

Trial Locations (1)

23230

Virginia Commonwealth University Parkinson's Center, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER

NCT02005029 - Erythromycin in Parkinson's Disease | Biotech Hunter | Biotech Hunter